Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy

Jun Ho Yi; Seok Jin Kim; Young Hyeh Ko; Won Seog Kim

doi:10.3109/10428194.2010.529203

Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy

Jun Ho Yi
, Seok Jin Kim
, Young Hyeh Ko
, Won Seog Kim

Sungkyunkwan University

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English
Pages (from-to)	317-320
Number of pages	4
Journal	Leukemia and Lymphoma
Volume	52
Issue number	2
DOIs	https://doi.org/10.3109/10428194.2010.529203
State	Published - Feb 2011
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.3109/10428194.2010.529203

Cite this

@article{1122e59659c0418fa5aa1e8e6c67fc1f,

title = "Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy",

author = "Yi, \{Jun Ho\} and Kim, \{Seok Jin\} and Ko, \{Young Hyeh\} and Kim, \{Won Seog\}",

year = "2011",

month = feb,

doi = "10.3109/10428194.2010.529203",

language = "English",

volume = "52",

pages = "317--320",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Taylor and Francis Ltd.",

number = "2",

}

TY - JOUR

T1 - Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy

AU - Yi, Jun Ho

AU - Kim, Seok Jin

AU - Ko, Young Hyeh

AU - Kim, Won Seog

PY - 2011/2

Y1 - 2011/2

UR - https://www.scopus.com/pages/publications/79551639443

U2 - 10.3109/10428194.2010.529203

DO - 10.3109/10428194.2010.529203

M3 - Letter

C2 - 21067447

AN - SCOPUS:79551639443

SN - 1042-8194

VL - 52

SP - 317

EP - 320

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 2

ER -

Treatment of patients with refractory diffuse large B-cell lymphoma or mantle cell lymphoma with alemtuzumab, alone or in combination with cytotoxic chemotherapy

UN SDGs

Access to Document

Other files and links

Cite this